Trials / Completed
CompletedNCT03084965
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,987 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 99 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan.
Conditions
Timeline
- Start date
- 2017-05-12
- Primary completion
- 2018-03-02
- Completion
- 2018-03-02
- First posted
- 2017-03-21
- Last updated
- 2019-02-26
Locations
8 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03084965. Inclusion in this directory is not an endorsement.